No shortage on file

SODIUM THIOSULFATE INJECTION USP

PFIZER CANADA ULC

Quick answers

Is there a shortage of SODIUM THIOSULFATE INJECTION USP in Canada?

No. There is no current shortage of SODIUM THIOSULFATE INJECTION USP 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file4 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SODIUM THIOSULFATE INJECTION USP

HOPE PHARMACEUTICALS LTD

250MG · DIN 02428393

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SEACALPHYX

SEAFORD PHARMACEUTICALS INC

250MG · DIN 02386666

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

SODIUM THIOSULFATE INJ 25% USP

DAVID BULL LABORATORIES (PTY) LTD.

250MG · DIN 01908820

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

OLIGOSTIM SOUFRE

DOLISOS CANADA INC.

0.015MG · DIN 02231305

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Sodium Acetate Injection USP

Sodium Acetate Injection USP; Incorrect GTIN

Type II2025-03-05

Moderate health risk

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter

2022-03-15

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP: Particulate matter

Type I2022-03-07

Highest health risk

Possible match — not confirmed

DIN

02137186

Strength

250MG

Dosage Form

Solution

Route

Intravenous

Active Ingredient

SODIUM THIOSULFATE

See all SODIUM THIOSULFATE products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from PFIZER CANADA ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

40MG · DIN 02511053

20MG · DIN 02511061

40MG · DIN 02511045

DIN 02544040

5MG · DIN 01947664

10MG · DIN 01947672